INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo VICKS ACTA PLUS EXPECTORANT COUGH SYRUP

SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form):

VICKS ACTA PLUS EXPECTORANT COUGH SYRUP

COMPOSITION
Each 15 mL contains:
Guaiphenesin 200 mg
Alcohol (100%) 9,96% v/v
Sodium Benzoate added as preservative 0,1%

PHARMACOLOGICAL CLASSIFICATION
A 10.1 Antitussives and Expectorants

PHARMACOLOGICAL ACTION
Guaiphenesin is an expectorant.

INDICATIONS
For the alleviation of cough.

CONTRA-INDICATIONS
Do not use if there is a known hypersensitivity to any of the ingredients.

WARNINGS
Do not exceed the recommended dose.
Do not use in children under 2 years of age except on medical advice.
If symptoms persist, consult your doctor.

DOSAGE AND DIRECTIONS FOR USE
Shake well before use.

Adults and children over 12 years. Three medicine measuresful (15 mL)
Children 6-11 years. Two medicine measuresful (10 mL)
Repeat every four hours as needed. No more than six doses per day.

SIDE EFFECTS AND SPECIAL PRECAUTIONS
Guaiphenesin:
Guaiphenesin may cause gastro-intestinal discomfort. Very large doses cause nausea and vomiting.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
See also "Side Effects and Special Precautions".
Treatment is supportive and symptomatic.

IDENTIFICATION
Vicks Acta Plus Expectorant Cough Syrup is an orange, opaque, viscous liquid with a menthol/orange flavour and aroma.

PRESENTATION
Bottles of 50 mL and 100 mL.

STORAGE DIRECTIONS
Store below 25°C. Keep out of reach of children.

REGISTRATION NUMBER
S/10.1/160

NAME AND BUSINESS ADDRESS OF APPLICANT
Procter & Gamble SA (Pty) Ltd.
Reg. No 57/03295/07
25 Newton Street
Spartan
KEMPTON PARK
1619

DATE AND PUBLICATION OF THIS PACKAGE INSERT
30 November 1993

VICKS is a registered trademark.

Red PMS 186 C O/N 36734 Rosside 29495
Included on this site: August 1996
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2008